{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:43:22Z","timestamp":1790855002719,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.jaci.2006.03.005","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T09:09:41Z","timestamp":1146647381000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Activation of T cells by carbamazepine and carbamazepine metabolites"],"prefix":"10.1016","volume":"118","author":[{"given":"Ying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola S.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bowkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Stachulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner J.","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Kevin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Naisbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2006.03.005_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0091-6749(00)90191-X","article-title":"Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response","volume":"105","author":"Leyva","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib2","first-page":"690","article-title":"Characterization of drug-specific CD4(+) T-cells expressing the skin homing receptor CCR10 in lamotrigine hypersensitivity","volume":"57","author":"Farrell","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2006.03.005_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2006.03.005_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.61.5.643","article-title":"Studies on the sensitization of animals with simple chemical compounds","volume":"61","author":"Landsteiner","year":"1935","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2006.03.005_bib5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"Naisbitt","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2006.03.005_bib6","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","article-title":"Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells","volume":"132","author":"Burkhart","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2006.03.005_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific T cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib9","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1365-2222.2002.01513.x","article-title":"Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides","volume":"32","author":"Burkhart","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.03.005_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.03.005_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2006.03.005_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcc.540150207","article-title":"Derivation of class-II force fields, 1: methodology and quantum force field for the alkyl functional group and alkane molecules","volume":"15","author":"Maple","year":"1994","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jaci.2006.03.005_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-2836(69)90421-5","article-title":"Refinement of protein conformations using a macromolecular energy minimization procedure","volume":"46","author":"Levitt","year":"1969","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jaci.2006.03.005_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI3544","article-title":"HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes","volume":"102","author":"Zanni","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2006.03.005_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0040-4020(84)85056-5","article-title":"Autocatalytic inactivation of cytochrome P-450 and chloroperoxidase by 1-aminobenzotriazole and other aryne precursors","volume":"40","author":"Ortiz De Montellano","year":"1984","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jaci.2006.03.005_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-9556(25)07375-1","article-title":"Bioactivation of carbamazepine in the rat in-vivo: evidence for the formation of reactive arene oxide(s)","volume":"24","author":"Madden","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaci.2006.03.005_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0091-6749(88)90059-0","article-title":"In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10,11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity","volume":"82","author":"Zakrzewska","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.155.1.462","article-title":"Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine","volume":"155","author":"Mauri-Hellweg","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1469-8749.1999.tb00596.x","article-title":"Carbamazepine hypersensitivity and the use of lymphocyte proliferation responses","volume":"41","author":"Brown","year":"1999","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jaci.2006.03.005_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions","volume":"31","author":"Hari","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.03.005_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.30.11.1170","article-title":"Pathways of carbamazepine bioactivation in vitro I: characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites","volume":"30","author":"Pearce","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaci.2006.03.005_bib22","first-page":"275","article-title":"Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography\/mass spectrometry","volume":"25","author":"Maggs","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaci.2006.03.005_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1528-1157.1995.tb00991.x","article-title":"Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood","volume":"36","author":"Pienimaki","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaci.2006.03.005_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0192-0561(95)00019-X","article-title":"The effect of carbamazepine and its reactive metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro","volume":"17","author":"Furst","year":"1995","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.jaci.2006.03.005_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(24)37923-6","article-title":"Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate","volume":"288","author":"Ju","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2006.03.005_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archneur.1980.00500600047009","article-title":"Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration","volume":"37","author":"Tomson","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaci.2006.03.005_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2003.11.030","article-title":"Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity","volume":"113","author":"Depta","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.03.005_bib29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome: in vitro risk assessment","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2006.03.005_bib30","first-page":"297","article-title":"Oxcarbazepine in patients hypersensitive to carbamazepine","volume":"155","author":"Jenson","year":"1986","journal-title":"Irish J Med Sci"},{"key":"10.1016\/j.jaci.2006.03.005_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00609428","article-title":"First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite","volume":"37","author":"Dickinson","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2006.03.005_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906006476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906006476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:02:58Z","timestamp":1758776578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674906006476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0091674906006476"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2006.03.005","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of T cells by carbamazepine and carbamazepine metabolites","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2006.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}